Suja Life's first quarter 2026 revenue of $107.1M missed estimates while gross margins expanded to 50.5%.

Suja Life reported first quarter 2026 net sales of $107.1 million, a 22.5% increase year-over-year, alongside a net income of $7.7 million, a significant improvement from a net loss of $0.8 million in the prior year. The company initiated its full fiscal year 2026 guidance, forecasting continued sales and profitability growth.

Key Highlights

• Gross margin expanded to 50.5% from 49.8% year-over-year, driven by improved production efficiencies and a favorable product mix of higher-margin wellness shots.
• Adjusted EBITDA grew 66.3% to $25.0 million, with margins increasing to 23.4% from 17.2% in the prior-year period due to gross margin expansion and SG&A leverage.
• The company initiated fiscal year 2026 guidance, expecting net sales between $367 million and $371 million and Adjusted EBITDA between $70 million and $72 million.